Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium falciparum | 17 | 2023 | 132 | 3.140 |
Why?
|
| Antimalarials | 12 | 2024 | 68 | 2.680 |
Why?
|
| Erythrocytes | 14 | 2023 | 155 | 1.990 |
Why?
|
| Malaria, Cerebral | 6 | 2024 | 21 | 1.710 |
Why?
|
| Malaria, Falciparum | 8 | 2023 | 115 | 1.400 |
Why?
|
| Angiotensin II | 8 | 2024 | 24 | 1.160 |
Why?
|
| Malaria | 6 | 2020 | 101 | 1.150 |
Why?
|
| Plasmodium gallinaceum | 4 | 2017 | 4 | 0.780 |
Why?
|
| Brain Edema | 2 | 2022 | 31 | 0.760 |
Why?
|
| Bradykinin | 2 | 2023 | 8 | 0.700 |
Why?
|
| Plasmodium berghei | 7 | 2024 | 20 | 0.620 |
Why?
|
| Peptides | 6 | 2024 | 549 | 0.590 |
Why?
|
| Proteinuria | 2 | 2019 | 37 | 0.560 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2019 | 18 | 0.560 |
Why?
|
| Cell Adhesion | 3 | 2023 | 211 | 0.520 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 82 | 0.510 |
Why?
|
| Life Cycle Stages | 3 | 2020 | 14 | 0.500 |
Why?
|
| Erythrocyte Membrane | 2 | 2020 | 24 | 0.450 |
Why?
|
| Endothelial Cells | 3 | 2023 | 177 | 0.400 |
Why?
|
| Leishmania mexicana | 2 | 2012 | 6 | 0.400 |
Why?
|
| Protective Agents | 2 | 2019 | 10 | 0.380 |
Why?
|
| Eugenol | 1 | 2020 | 4 | 0.370 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2020 | 1 | 0.370 |
Why?
|
| Elastic Modulus | 1 | 2020 | 35 | 0.360 |
Why?
|
| Elasticity | 1 | 2020 | 35 | 0.350 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 2064 | 0.340 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 128 | 0.340 |
Why?
|
| Lithium Carbonate | 1 | 2019 | 11 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3191 | 0.320 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2019 | 17 | 0.320 |
Why?
|
| Animals | 19 | 2024 | 19620 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 185 | 0.300 |
Why?
|
| Renin-Angiotensin System | 2 | 2016 | 22 | 0.280 |
Why?
|
| Heterocyclic Compounds | 1 | 2016 | 12 | 0.270 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2016 | 1 | 0.270 |
Why?
|
| Monocytes | 2 | 2023 | 351 | 0.270 |
Why?
|
| Protozoan Proteins | 1 | 2016 | 80 | 0.260 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 54 | 0.250 |
Why?
|
| Peroxides | 1 | 2015 | 11 | 0.250 |
Why?
|
| Mice | 10 | 2024 | 10260 | 0.250 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 127 | 0.250 |
Why?
|
| Lipoxins | 1 | 2015 | 7 | 0.240 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 18 | 0.240 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 52 | 0.240 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2014 | 10 | 0.240 |
Why?
|
| Serum Albumin | 1 | 2014 | 38 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 315 | 0.230 |
Why?
|
| Biological Products | 1 | 2015 | 94 | 0.230 |
Why?
|
| Epithelial Cells | 2 | 2019 | 375 | 0.220 |
Why?
|
| Cell Line | 5 | 2019 | 2014 | 0.220 |
Why?
|
| Kidney Diseases | 1 | 2014 | 157 | 0.210 |
Why?
|
| Eye Infections, Parasitic | 1 | 2012 | 1 | 0.210 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2012 | 12 | 0.210 |
Why?
|
| Eye | 1 | 2012 | 54 | 0.200 |
Why?
|
| Parasitemia | 3 | 2022 | 32 | 0.200 |
Why?
|
| Hemolysis | 3 | 2016 | 38 | 0.190 |
Why?
|
| Spleen | 1 | 2013 | 485 | 0.190 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2013 | 236 | 0.190 |
Why?
|
| Lymphocytes | 1 | 2022 | 194 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 30 | 0.180 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2011 | 26 | 0.180 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2020 | 4 | 0.180 |
Why?
|
| Receptors, CXCR4 | 1 | 2020 | 32 | 0.180 |
Why?
|
| Humans | 20 | 2024 | 59343 | 0.180 |
Why?
|
| Rheology | 2 | 2020 | 65 | 0.180 |
Why?
|
| Plasmodium | 1 | 2020 | 29 | 0.170 |
Why?
|
| Extracellular Traps | 1 | 2020 | 40 | 0.170 |
Why?
|
| Gonorrhea | 1 | 2022 | 196 | 0.170 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2022 | 258 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2015 | 842 | 0.160 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2018 | 7 | 0.160 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2020 | 90 | 0.150 |
Why?
|
| Neutrophils | 1 | 2020 | 356 | 0.150 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 60 | 0.140 |
Why?
|
| Adenosine | 1 | 2017 | 70 | 0.140 |
Why?
|
| Kidney | 2 | 2018 | 391 | 0.140 |
Why?
|
| Group V Phospholipases A2 | 1 | 2016 | 1 | 0.130 |
Why?
|
| Kidney Tubules, Distal | 1 | 2016 | 4 | 0.130 |
Why?
|
| Sodium | 1 | 2016 | 60 | 0.130 |
Why?
|
| Kidney Glomerulus | 2 | 2014 | 19 | 0.120 |
Why?
|
| Cell Movement | 2 | 2019 | 422 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2014 | 30 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 880 | 0.120 |
Why?
|
| Culture Media, Conditioned | 1 | 2023 | 50 | 0.110 |
Why?
|
| Monoterpenes | 1 | 2022 | 8 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 288 | 0.100 |
Why?
|
| Male | 7 | 2020 | 27505 | 0.100 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2018 | 26 | 0.090 |
Why?
|
| Blood Viscosity | 1 | 2020 | 4 | 0.090 |
Why?
|
| Drug Design | 2 | 2017 | 143 | 0.090 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 451 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 580 | 0.090 |
Why?
|
| Viscosity | 1 | 2020 | 43 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2016 | 2103 | 0.090 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2019 | 2 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 97 | 0.080 |
Why?
|
| Albumins | 1 | 2019 | 32 | 0.080 |
Why?
|
| Actins | 1 | 2020 | 260 | 0.080 |
Why?
|
| Endocytosis | 1 | 2019 | 148 | 0.080 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2016 | 6 | 0.070 |
Why?
|
| Aedes | 1 | 2015 | 12 | 0.060 |
Why?
|
| Chickens | 1 | 2015 | 91 | 0.060 |
Why?
|
| Sporozoites | 1 | 2015 | 4 | 0.060 |
Why?
|
| Artemisinins | 1 | 2015 | 13 | 0.060 |
Why?
|
| Stomach | 1 | 2015 | 84 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 119 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 183 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 475 | 0.060 |
Why?
|
| Kidney Cortex | 1 | 2014 | 10 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2015 | 198 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 285 | 0.060 |
Why?
|
| Cattle | 1 | 2014 | 306 | 0.060 |
Why?
|
| Apoptosis | 1 | 2019 | 1038 | 0.060 |
Why?
|
| Swine | 1 | 2014 | 339 | 0.060 |
Why?
|
| Collagen | 1 | 2014 | 121 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2014 | 298 | 0.050 |
Why?
|
| Macrophages | 1 | 2019 | 1006 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 34 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 36 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 47 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2012 | 112 | 0.050 |
Why?
|
| Homeostasis | 2 | 2016 | 340 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1537 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 97 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 169 | 0.050 |
Why?
|
| Protein Binding | 1 | 2016 | 1551 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 454 | 0.050 |
Why?
|
| Bacterial Vaccines | 1 | 2022 | 90 | 0.050 |
Why?
|
| Vacuoles | 1 | 2011 | 27 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2014 | 353 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2022 | 126 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 307 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 309 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 740 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 1095 | 0.040 |
Why?
|
| Cytokines | 1 | 2013 | 906 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2019 | 2890 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 645 | 0.040 |
Why?
|
| Captopril | 1 | 2018 | 8 | 0.040 |
Why?
|
| Losartan | 1 | 2018 | 18 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 198 | 0.040 |
Why?
|
| Chemical Engineering | 1 | 2017 | 9 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2017 | 19 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 141 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 594 | 0.040 |
Why?
|
| Brain | 1 | 2015 | 1489 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2016 | 23 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2466 | 0.030 |
Why?
|
| Trophozoites | 1 | 2014 | 6 | 0.030 |
Why?
|
| Time Factors | 1 | 2011 | 3569 | 0.030 |
Why?
|
| Biological Transport | 1 | 2014 | 287 | 0.030 |
Why?
|
| Kinetics | 1 | 2014 | 733 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 250 | 0.020 |
Why?
|
| Schizonts | 1 | 2011 | 1 | 0.020 |
Why?
|
| Angiotensin I | 1 | 2011 | 2 | 0.020 |
Why?
|
| Female | 2 | 2022 | 30847 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 807 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 1909 | 0.020 |
Why?
|
de Souza Silva's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(159)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_